CNIPA.AI

Company patentsPharmaceuticals and diagnostics

COMPANY PATENT INTELLIGENCE

Roche Patent Portfolio Analysis

Explore drug-delivery and pharmaceutical technologies through the selected F. Hoffmann-La Roche legal entity.

Partial name or date coverage · counts are lower boundsData as of 2026-11-17Data scope
Search jurisdictions
Worldwide
Applicant-name basis
Dataset-harmonized assignees (not verified current owners)
Source search matches
2,960
Published 2025-01-01 — 2025-12-31 · Source Google Patents
Applicant names included in these statistics
F HOFFMANN LA ROCHE AG · HOFFMANN LA ROCHE
Publication dates collected
Not recorded in this snapshot
Reviewed names not covered
F. HOFFMANN-LA ROCHE AG · F. HOFFMANN-LA ROCHE LTD
Compare with other companies
Collected patent publications

≥2,960docs

247 per month · peak 2025-03 (446)

Empty dashed outlines are uncollected periods, not zero. Dashed bars have partial name or date coverage.

01Key figures

Applications
2,756
By application number; publication and grant count once
Invention
1,620
59% of applications
Utility model
0
0% of applications
Patent families
1,265
By the source family ID
Green technology
—
The source has no CPC codes
Concentration
0.47HHI
Sum of squared field shares; higher is more concentrated

INSIGHT 01Fact

48%

48% of applications are in Pharmaceuticals

1,274 applications in this field, 1,137 of them in IPC A61K — the main axis of the portfolio.

Method: Field applications ÷ applications with IPC

INSIGHT 02Fact

15%

15% involve manufacturing and inspection

Measurement, machine tools, handling and chemical engineering together reach 425, mostly production-line, equipment and inspection filings.

Method: Four fields added ÷ all applications (fields may overlap)

02Technology landscape

2,673 applications with IPC codes are mapped to 35 fields using the WIPO IPC–Technology Concordance; area is the number of applications. Select a tile to see its IPC subclasses. An application can belong to several fields.

  • Electrical engineering
  • Instruments
  • Chemistry
  • Mechanical engineering
Explore reviewed themes, sample patents and evidence

03Rhythm

Publications per month in each field; brighter cells mean more. It shows which directions surge in particular months.

This chart covers collected documents published from 2025-01-01 to 2025-12-31. Examination and publication processes affect this timing; it does not directly measure R&D investment in the same period.

Cells count publications only within the collected names and dates. Missing periods are not shown; the company portfolio is incomplete.
Technology field25-0125-0225-0325-0425-0525-0625-0725-0825-0925-1025-1125-12
Pharmaceuticals140109224128126116887986848981
Biotechnology9989138918897647571787460
Organic fine chemistry6259138706960533147353838
Medical technology475163393942374537313940
Measurement192046272822362818291814
Analysis of biological materials201738222321221420201615
Computer technology1491512172018211213268
Chemical engineering1791511145693654

Filing years of the collected applications

Documents in the current publication window are deduplicated by application number and grouped by filing year. These are not the company's complete annual filings; older applications may only be published or granted within this window.

  • 20031
  • 20072
  • 200811
  • 200917
  • 201012
  • 20117
  • 201225
  • 20138
  • 201433
  • 201581
  • 2016130
  • 201798
  • 2018156
  • 2019168
  • 2020173
  • 2021144
  • 2022125
  • 2023671
  • 2024562
  • 2025332Publication lag may still apply

Invention applications are generally published about 18 months after filing, or priority where claimed, and may be published earlier. Flags are estimated as of 2026-11-17. An unflagged year is still not necessarily complete; these counts cannot establish growth or contraction in R&D.

Multi-year evolution · With a longer collection window, this becomes a yearly view that marks the fastest-growing and shrinking fields.

04Strategy profile

Four reproducible structural ratios, with the other published companies on the same scale. Entity scopes and windows can differ, so read relative positions only — this is not a ranking.

Concentration

0.47
0.001.43

Position 19 of 26 published companies.

Method: Sum of squared field shares

Utility model share

0%
0%33%

Position 9 of 26 published companies.

Method: Utility model documents ÷ all documents

Green technology share

—

The source has no CPC codes, so this cannot be computed.

Method: Documents with CPC Y02 ÷ documents with CPC

Manufacturing and inspection share

15%
0%50%

Position 3 of 26 published companies.

Method: Applications in measurement, chemical engineering, handling and machine tools ÷ all applications

05Collaboration

Organisations that filed jointly with the collected entities; line weight represents joint applications. Name-based candidates and reviewed relationships are labeled separately. Co-applications alone do not prove ownership.

ROCHE DIAGNOSTICS GMBH252Other co-applicant · relationship unverified
GENENTECH INC244Other co-applicant · relationship unverified
ROCHE DIABETES CARE GMBH84Other co-applicant · relationship unverified
ROCHE DIAGNOSTICS OPERATIONS INC43Other co-applicant · relationship unverified
CHUGAI PHARMACEUTICAL CO LTD41Other co-applicant · relationship unverified
HITACHI HIGH TECH CORP15Other co-applicant · relationship unverified
ROCHE SEQUENCING SOLUTIONS INC15Other co-applicant · relationship unverified
VENTANA MED SYST INC14Other co-applicant · relationship unverified
ROCHE DIABETES CARE INC11Other co-applicant · relationship unverified
ROCHE MOLECULAR SYSTEMS INC9Other co-applicant · relationship unverified

Possible affiliation is a review lead only. Co-applicants without a review record are not automatically group members or external partners, and their independent filings are not added to these statistics.

Review the entity list

06Entities and scope

Entity review and data coverage are separate facts. This list shows the current entity configuration, evidence and relationship dates, matched name by name against this snapshot.

Filters change only the entity list below, not the statistics. A complete group snapshot is not available to switch to on this page.

Showing 1 of 1 entities

F. Hoffmann-La Roche AG

Other relationshipVerifiedSome names covered
Names collected in this snapshot
HOFFMANN LA ROCHE · F HOFFMANN LA ROCHE AG
Names outside this snapshot
F. Hoffmann-La Roche AG · F. Hoffmann-La Roche Ltd
Recorded relationship dates
Not recorded — Not recorded

仅观察豪夫迈·罗氏这一已核验法人,relation=other 不将其误标为上市控股母公司。标准名来自原始申请人交叉核对;不扩展至 Genentech、诊断子公司或中外制药的独立文献。

Review evidence

Relationship dates help interpret renaming, acquisitions and joint ventures. Missing dates do not establish an indefinite relationship or verify the current patent owner.

07Observations

Written by editors after reading the patent texts and company materials. Verified facts and inferences are labeled, each with evidence and limits.

Technology themes and evidence

Select a theme to filter reviewed patents and observations that cite them. Counts are editorial samples only; one patent may belong to several themes. They do not describe the full portfolio distribution.

Themes describe the technical directions in these samples. Links to adoption in specific products, commercialization or commercial value have not been established.

Showing 2 sample patents · 0 linked observations

Reading samples

Hand-picked documents that illustrate technology themes — not a ranking of core patents and not representative of the whole.

US20250001031A1

Particle counter and method for counting particles in a sterilization tunnel of a medicament filling system

The abstract places particle counting within a sterilisation tunnel of a medicament filling system. Claim 1 combines a probe, holder, transverse linear guide, bogie moving along the conveyor direction and scanner controller. The reading concerns coordinated inspection hardware and transport geometry in pharmaceutical manufacturing.

Bibliography and claim evidence
Applicants
Hoffmann-La Roche Inc.
Application date
2022-07-26
Publication date
2025-01-02
English summary of cited claim evidence
US20250001031A1, claim 1 (reading note, not a verbatim quotation)The abstract places particle counting within a sterilisation tunnel of a medicament filling system. Claim 1 combines a probe, holder, transverse linear guide, bogie moving along the conveyor direction and scanner controller. The reading concerns coordinated inspection hardware and transport geometry in pharmaceutical manufacturing.
Legal status
Legal status and current ownership are unverified; applicant names retain the original source attribution.

US20250034538A1

Fusion proteins targeted to the central nervous system

The abstract proposes fusion proteins targeted to the central nervous system. Claim 1 requires a lysosomal protein, an antibody Fc region and a transferrin-receptor-targeting antibody fragment with monovalent binding. This identifies an integrated protein and receptor-binding design; the publication alone does not establish brain delivery efficiency or clinical benefit.

Bibliography and claim evidence
Applicants
Hoffmann-La Roche Inc.
Application date
2024-10-10
Publication date
2025-01-30
English summary of cited claim evidence
US20250034538A1, claim 1 (reading note, not a verbatim quotation)The abstract proposes fusion proteins targeted to the central nervous system. Claim 1 requires a lysosomal protein, an antibody Fc region and a transferrin-receptor-targeting antibody fragment with monovalent binding. This identifies an integrated protein and receptor-binding design; the publication alone does not establish brain delivery efficiency or clinical benefit.
Legal status
Legal status and current ownership are unverified; applicant names retain the original source attribution.

08Publication jurisdictions

41 publication offices · 2,960 documents

Counts use the publication office of each collected document, retaining publications from the same family in different jurisdictions. This is not a map of complete families, granted or active rights; WO and EP denote international and European publication routes.

  1. EPEuropean Patent Office publication739
  2. USUnited States317
  3. CNChina307
  4. WOPCT international publication246
  5. MXMexico174
  6. TWTaiwan168
  7. ILIsrael125
  8. ESSpain119
Show 33 more jurisdictions
  1. AUAustralia115
  2. KRSouth Korea111
  3. JPJapan79
  4. PLPoland59
  5. ARArgentina53
  6. HUHungary48
  7. HRCroatia26
  8. CLChile22
  9. SISlovenia22
  10. DKDenmark20
  11. PEPeru19
  12. FIFinland17
  13. LTLithuania17
  14. COColombia16
  15. CRCosta Rica16
  16. RSSerbia16
  17. PTPortugal14
  18. MAMorocco13
  19. CACanada12
  20. NZNew Zealand12
  21. SMSan Marino12
  22. MYMalaysia10
  23. ZASouth Africa10
  24. UAUkraine7
  25. CYCyprus5
  26. NONorway4
  27. FRFrance3
  28. SASaudi Arabia2
  29. DEGermany1
  30. GBUnited Kingdom1
  31. LULuxembourg1
  32. NLNetherlands1
  33. TNTunisia1

09Documents

11 published documentsClear filtersNewest first
  1. Methods and devices for controlling auto white balance settings of a mobile device for a color based measurement using a color reference card

    HOFFMANN LA ROCHE

    Audio-visual technologyMeasurement

    2025-10-22
  2. Methods and devices for controlling auto white balance settings of a mobile device for a color based measurement using a color reference card

    HOFFMANN LA ROCHE

    Audio-visual technologyMeasurement

    2025-10-06
  3. Medical device and method for manufacturing a medical device

    HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-09-28
  4. Medical device and method for manufacturing a medical device

    HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-07-22
  5. EP4141860B1

    Invention grant

    Methods and devices for controlling auto white balance settings of a mobile device for a color based measurement using a color reference card

    ROCHE DIABETES CARE GMBH / HOFFMANN LA ROCHE

    Audio-visual technologyMeasurement

    2025-07-09
  6. Methods and devices for controlling auto white balance settings of a mobile device for a color based measurement using a color reference card

    ROCHE DIABETES CARE GMBH / HOFFMANN LA ROCHE

    Audio-visual technologyMeasurement

    2025-07-09
  7. WO2025140940A1

    Invention publication

    A method for evaluating the suitability of auto-exposure settings of a mobile device for performing a color based measurement

    HOFFMANN LA ROCHE / ROCHE DIABETES CARE GMBH / ROCHE DIABETES CARE INC

    Audio-visual technologyTelecommunicationsMeasurementMedical technology

    2025-07-03
  8. EP3600035B1

    Invention grant

    Medical device and method for manufacturing a medical device

    ROCHE DIABETES CARE GMBH / HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-04-23
  9. Medical device and method for manufacturing a medical device

    ROCHE DIABETES CARE GMBH / HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-04-23
  10. Medical device comprising a temperature sensitive activation label

    HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-04-01
  11. Sensor connector

    HOFFMANN LA ROCHE

    Audio-visual technologyMedical technology

    2025-03-16

Titles come from the source bibliography. Select a number to read the full document on this site.

Drafting a patent in this field?

Upload your invention disclosure and get an editable draft that follows CNIPA practice.

Start drafting

10Method and sources

Counting units

Publications are deduplicated by publication number; applications by application number, so a publication and its grant count once; families by the source family ID. Technology fields are derived automatically from IPC codes using the WIPO IPC–Technology Concordance (March 2026), without manual or AI labeling.

Publication or grant documents do not establish current rights. Check legal status and current owners with the relevant patent office.

Entity scope

These statistics use only the applicant names and publication dates collected for this snapshot. They do not represent the full company or group portfolio.

Search jurisdictions
Worldwide
Applicant-name basis
Dataset-harmonized assignees (not verified current owners)
Applicant names included in these statistics
F HOFFMANN LA ROCHE AG · HOFFMANN LA ROCHE
Reviewed names not covered
F. HOFFMANN-LA ROCHE AG · F. HOFFMANN-LA ROCHE LTD
Current entity configuration and review evidence

The reviewed entities and aliases below describe the current company configuration. Only names listed above are covered by this snapshot.

F. Hoffmann-La Roche AG

Configured aliases: F. Hoffmann-La Roche Ltd · HOFFMANN LA ROCHE · F HOFFMANN LA ROCHE AG

Original review note: 仅观察豪夫迈·罗氏这一已核验法人,relation=other 不将其误标为上市控股母公司。标准名来自原始申请人交叉核对;不扩展至 Genentech、诊断子公司或中外制药的独立文献。

Review evidence

Data sources

  • Google Patents · PartialPublished 2025-01-01 to 2025-12-31 · retrieved 2026-11-17 · 2,960 included · 0 out of scopeSource and terms

Found a wrong attribution or number? Tell us